首頁 > 市場調查報告書 > 製藥

孤兒藥

鐮狀細胞病治療市場- 按治療方式[輸血、藥物治療（羥基脲、Oxybryta、Endari）、骨髓移植]、按疾病（鐮狀細胞貧血、血紅蛋白Sickle C）、按最終用戶和預測，2023-2032年

市場調查報告書

商品編碼

1336641

鐮狀細胞病治療市場- 按治療方式[輸血、藥物治療（羥基脲、Oxybryta、Endari）、骨髓移植]、按疾病（鐮狀細胞貧血、血紅蛋白Sickle C）、按最終用戶和預測，2023-2032年

Sickle Cell Disease Treatment Market - By Treatment Modality [Blood Transfusion, Pharmacotherapy (Hydroxyurea, Oxybryta, Endari), Bone Marrow Transplant], By Disease (Sickle Cell Anemia, Hemoglobin Sickle C), By End-user & Forecast, 2023-2032

出版日期: 2023年05月15日 | 出版商:

Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023-2032年全球鐮狀細胞病治療市場將保持穩定成長。鐮狀細胞病的高患病率，特別是在撒哈拉以南非洲和中東的一些地區，需要有效的治療方案。據 CDC 稱，SCD 影響了大約 100,000 名美國人。此外，大約每 365 名黑人或非裔美國人新生兒中就有 1 人患有這種疾病。

醫學研究和技術的進步促進了新療法的發展，包括基因療法和靶向藥物，改善了患者的治療效果。此外，政府的舉措以及與製藥公司的合作也促進了更多的治療選擇。此外，醫療保健專業人員和患者對疾病早期診斷和管理重要性的認知不斷提高，進一步刺激了鐮狀細胞病治療市場對創新治療的需求。

總體市場佔有率根據治療方式、疾病、最終用戶和地區進行分類。

根據治療方式，骨髓移植領域將從2023 年到2032 年對市場收入做出重大貢獻。這種治療方案通過用來自相容捐贈者的健康幹細胞替換有缺陷的幹細胞，為鐮狀細胞病提供了潛在的治愈方法。隨著人們對這種治療方法的認知不斷增強，越來越多的患者和醫療保健專業人員正在考慮將骨髓移植作為一種可行的解決方案。移植技術的進步和對匹配標準的更好理解提高了成功率，使骨髓移植成為越來越受歡迎的選擇。

按疾病分類，血紅蛋白鐮狀細胞病(HbSC) 細分市場將在2023 年至2032 年期間呈現高成長率，並可能在2032 年主導鐮狀細胞病治療市場佔有率。HbSC 是鐮狀細胞病的一種較溫和的形式，但仍可能導致併發症並影響受影響個體的生活品質。隨著人們對HbSC 的認知和了解不斷增加，對標靶治療和支持性護理方案的需求不斷成長，以管理症狀並改善患者的整體健康狀況，從長遠來看，這將有利於細分市場的成長。

至於最終用戶，到 2032 年，鐮狀細胞治療行業的專科診所部分將錄得不錯的估值。這些診所提供管理鐮狀細胞病的專門護理和專業知識，為患者提供全面的治療方案和支持。專科診所專注於個性化護理和量身定做的治療計劃，在改善患者治療效果和生活品質方面發揮著至關重要的作用。人們對鐮狀細胞病專門護理重要性的認知不斷提高，導致鐮狀細胞病治療市場對這些診所的需求不斷成長。

從區域來看，由於該地區對鐮狀細胞病的認知不斷提高和診斷的改進，歐洲鐮狀細胞病治療市場將在預測期內獲得牽引力。該地區強大的醫療基礎設施以及先進的醫學研究和技術支持創新療法的開發和可用性。此外，政府的舉措以及與製藥公司的合作促進了該領域的研究和開發。對改善患者治療結果和提高生活品質的日益關注推動了歐洲對鐮狀細胞病治療的需求。

行業格局，2018 - 2032
行業影響力
- 成長動力
  - 鐮狀細胞病患病率增加
  - 增加鐮狀細胞病藥物開發的研發活動
  - 增加醫療支出和政府舉措
- 行業陷阱與挑戰
  - 與治療相關的高費用
  - 與鐮狀細胞病治療藥物相關的副作用
成長潛力分析
- 按治療方式
- 按疾病類型
- 按最終用戶
COVID-19 影響分析
臨床試驗分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局，2022 年

介紹
2022 年公司矩陣分析
2022 年全球公司市場佔有率分析
2022 年競爭定位矩陣
戰略儀表板，2022 年

第 5 章：鐮狀細胞病治療市場估計和預測：按治療方式

按治療方式分類的主要趨勢
輸血
藥物治療
- 按藥物類型
  - 羥基脲
  - 奧克西布里塔
  - 阿達克維奧
  - 恩達里
  - 其他藥物療法
- 按給藥途徑
  - 口服
  - 注射用
骨髓移植

第 6 章：鐮狀細胞病治療市場估計和預測：按疾病類型

按疾病類型分類的主要趨勢
鐮狀細胞性貧血
血紅蛋白鐮狀 C 病 (HbSC)
其他疾病類型

第 7 章：鐮狀細胞病治療市場估計和預測：按最終用戶

主要趨勢（按最終用戶）
醫院
專科診所
其他最終用戶

第 8 章：鐮狀細胞病治療市場估計和預測：按地區

按地區分類的主要趨勢
北美
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 瑞士
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- MEA 的其餘部分

第 9 章：公司簡介

Pfizer, Inc.
Novartis AG
Emmaus Medical, Inc.
Medunik USA, Inc.
Bristol-Myers Squibb Company
Bluebird Bio, Inc.
Agios Pharmaceuticals
CRISPR Therapeutics
Vifor Pharma
Editas Medicine Inc.

簡介目錄圖表

Product Code: 5697

Global Sickle Cell Disease Treatment Market will have a stable growth rate from 2023-2032. The high prevalence of sickle cell disease, particularly in sub-Saharan Africa and some parts of the Middle East, demands effective treatment options. According to CDC, SCD affects an estimated 100,000 Americans. Also, the disease occurs in about 1 in every 365 Black or African American births.

Advancements in medical research and technology have led to the development of novel therapies, including gene therapies and targeted drugs, improving patient outcomes. In addition, government initiatives and collaborations with pharmaceutical companies have facilitated increased access to treatment options. Moreover, growing awareness among healthcare professionals and patients about the importance of early diagnosis and management of the disease has further fuelled the demand for innovative treatments in the Sickle Cell Disease Treatment Market.

The overall market share is classified based on treatment modality, disease, end-user, and region.

Based on treatment modality, the bone marrow transplant segment will contribute significantly to the market revenue from 2023 to 2032. This treatment option offers a potential cure for sickle cell disease by replacing defective stem cells with healthy ones from a compatible donor. As awareness of this therapeutic approach grows, more patients and healthcare professionals are considering bone marrow transplants as a viable solution. Advances in transplant techniques and a better understanding of matching criteria have improved success rates, making bone marrow transplants an increasingly sought-after option.

By disease, the hemoglobin sickle C disease (HbSC) segment will show a high growth rate from 2023-2032 and could dominate the sickle cell disease treatment market share by 2032. HbSC is a milder form of sickle cell disease, but it can still cause complications and affect the quality of life for affected individuals. As awareness and understanding of HbSC increase, there is a growing need for targeted therapies and supportive care options to manage symptoms and improve patients' overall well-being, which will favor segment growth in the long run.

Regarding end-user, the specialty clinics segment of the sickle cell treatment industry will record a decent valuation by 2032. These clinics offer specialized care and expertise in managing sickle cell disease, providing comprehensive treatment options and support to patients. With a focus on personalized care and tailored treatment plans, specialty clinics play a crucial role in improving patient outcomes and quality of life. The rising awareness of the importance of specialized care for sickle cell disease has led to a growing demand for these clinics in the Sickle Cell Disease Treatment Market.

Regionally, the Europe sickle cell disease treatment market will gain traction during the forecast period due to increasing awareness and improved diagnosis of sickle cell disease in the region. The region's strong healthcare infrastructure and access to advanced medical research and technologies support the development and availability of innovative therapies. Additionally, government initiatives and collaborations with pharmaceutical companies promote research and development in the field. The growing focus on improving patient outcomes and enhancing quality of life drives the demand for sickle cell disease treatment in Europe.

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Secondary
  - 1.4.1.1 Paid sources
  - 1.4.1.2 Public sources
- 1.4.2 Primary

Chapter 2 Executive Summary

2.1 Sickle cell disease treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Region trends
- 2.1.3 Treatment modality trends
- 2.1.4 Disease type trends
- 2.1.5 End-user trends

Chapter 3 Sickle Cell disease Treatment Market Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of sickle cell disease
  - 3.2.1.2 Increasing R&D activities in drug development for sickle cell disease
  - 3.2.1.3 Increasing healthcare expenditure and government initiatives
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with the treatment
  - 3.2.2.2 Side effects associated with sickle cell disease treatment drugs
3.3 Growth potential analysis
- 3.3.1 By treatment modality
- 3.3.2 By disease type
- 3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Clinical trial analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Sickle Cell Disease Treatment Market Estimates and Forecast, By Treatment Modality (USD Million)

5.1 Key trends, by treatment modality
5.2 Blood transfusion
5.3 Pharmacotherapy
- 5.3.1 By drug type
  - 5.3.1.1 Hydroxyurea
  - 5.3.1.2 Oxybryta
  - 5.3.1.3 Adakveo
  - 5.3.1.4 Endari
  - 5.3.1.5 Other pharmacotherapies
- 5.3.2 By route of administration
  - 5.3.2.1 Oral
  - 5.3.2.2 Parenteral
5.4 Bone marrow transplant

Chapter 6 Sickle Cell Disease Treatment Market Estimates and Forecast, By Disease Type (USD Million)

6.1 Key trends, by disease type
6.2 Sickle cell anemia
6.3 Hemoglobin sickle C disease (HbSC)
6.4 Other disease types

Chapter 7 Sickle Cell Disease Treatment Market Estimates and Forecast, By End-user (USD Million)

7.1 Key trends, by end-user
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end-users

Chapter 8 Sickle Cell Disease Treatment Market Estimates and Forecast, By Region (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Switzerland
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of MEA

Chapter 9 Company Profiles

9.1 Pfizer, Inc.
9.2 Novartis AG
9.3 Emmaus Medical, Inc.
9.4 Medunik USA, Inc.
9.5 Bristol-Myers Squibb Company
9.6 Bluebird Bio, Inc.
9.7 Agios Pharmaceuticals
9.8 CRISPR Therapeutics
9.9 Vifor Pharma
9.10 Editas Medicine Inc.

簡介目錄圖表

Data Tables

TABLE 1 Product mapping
TABLE 2 Market revenue, by treatment modality (2022)
TABLE 3 Market revenue, by disease type (2022)
TABLE 4 Market revenue, by end-user (2022)
TABLE 5 Market share, by region (2022)
TABLE 6 Global sickle cell disease treatment market size, by region, 2018 - 2022 (USD Million)
TABLE 7 Global sickle cell disease treatment market size, by region, 2023 - 2032 (USD Million)
TABLE 8 Global sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 9 Global sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 10 Global sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 11 Global sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 12 Global sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 13 Global sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 14 Industry impact forces
TABLE 15 Competitive benchmarking of major market players
TABLE 16 Competitive positioning matrix: Classification criteria
TABLE 17 Strategic outlook matrix: Classification criteria
TABLE 18 Blood transfusion market size, 2018 - 2022 (USD Million)
TABLE 19 Blood transfusion market size, 2023 - 2032 (USD Million)
TABLE 20 Pharmacotherapy market size, 2018 - 2022 (USD Million)
TABLE 21 Pharmacotherapy market size, 2023 - 2032 (USD Million)
TABLE 22 Pharmacotherapy market size, by drug type, 2018 - 2022 (USD Million)
TABLE 23 Pharmacotherapy market size by drug type, 2023 - 2032 (USD Million)
TABLE 24 Hydroxyurea market size, 2018 - 2022 (USD Million)
TABLE 25 Hydroxyurea market size, 2023 - 2032 (USD Million)
TABLE 26 Oxybryta market size, 2018 - 2022 (USD Million)
TABLE 27 Oxybryta market size, 2023 - 2032 (USD Million)
TABLE 28 Adakveo market size, 2018 - 2022 (USD Million)
TABLE 29 Adakveo market size, 2023 - 2032 (USD Million)
TABLE 30 Endari market size, 2018 - 2022 (USD Million)
TABLE 31 Endari market size, 2023 - 2032 (USD Million)
TABLE 32 Other pharmacotherapies market size, 2018 - 2022 (USD Million)
TABLE 33 Other pharmacotherapies market size, 2023 - 2032 (USD Million)
TABLE 34 Pharmacotherapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 35 Pharmacotherapy market size, by route of administration, 2023 - 2032 (USD Million)
TABLE 36 Oral market size, 2018 - 2022 (USD Million)
TABLE 37 Oral market size, 2023 - 2032 (USD Million)
TABLE 38 Parenteral market size, 2018 - 2022 (USD Million)
TABLE 39 Parenteral market size, 2023 - 2032 (USD Million)
TABLE 40 Bone marrow transplant market size, 2018 - 2022 (USD Million)
TABLE 41 Bone marrow transplant market size, 2023 - 2032 (USD Million)
TABLE 42 Sickle cell anemia market size, 2018 - 2022 (USD Million)
TABLE 43 Sickle cell anemia market size, 2023 - 2032 (USD Million)
TABLE 44 Hemoglobin sickle C disease (HbSC) market size, 2018 - 2022 (USD Million)
TABLE 45 Hemoglobin sickle C disease (HbSC) market size, 2023 - 2032 (USD Million)
TABLE 46 Other disease types market size, 2018 - 2022 (USD Million)
TABLE 47 Other disease types market size, 2023 - 2032 (USD Million)
TABLE 48 Hospitals market size, 2018 - 2022 (USD Million)
TABLE 49 Hospitals market size, 2023 - 2032 (USD Million)
TABLE 50 Specialty clinics market size, 2018 - 2022 (USD Million)
TABLE 51 Specialty clinics market size, 2023 - 2032 (USD Million)
TABLE 52 Other end-users market size, 2018 - 2022 (USD Million)
TABLE 53 Other end-users market size, 2023 - 2032 (USD Million)
TABLE 54 North America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 55 North America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 56 North America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 57 North America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 58 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 59 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 60 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 61 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 62 North America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 63 North America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 64 North America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 65 North America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 66 U.S. sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 67 U.S. sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 68 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 69 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 70 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 71 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 72 U.S. sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 73 U.S. sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 74 U.S. sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 75 U.S. sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 76 Canada sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 77 Canada sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 78 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 79 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 80 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 81 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 82 Canada sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 83 Canada sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 84 Canada sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 85 Canada sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 86 Europe sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 87 Europe sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 88 Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 89 Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 90 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 91 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 92 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 93 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 94 Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 95 Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 96 Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 97 Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 98 Germany sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 99 Germany sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 100 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 101 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 102 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 103 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 104 Germany sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 105 Germany sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 106 Germany sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 107 Germany sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 108 UK sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 109 UK sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 110 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 111 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 112 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 113 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 114 UK sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 115 UK sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 116 UK sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 117 UK sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 118 France sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 119 France sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 120 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 121 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 122 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 123 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 124 France sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 125 France sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 126 France sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 127 France sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 128 Spain sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 129 Spain sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 130 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 131 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 132 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 133 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 134 Spain sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 135 Spain sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 136 Spain sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 137 Spain sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 138 Italy sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 139 Italy sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 140 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 141 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 142 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 143 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 144 Italy sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 145 Italy sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 146 Italy sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 147 Italy sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 148 Switzerland sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 149 Switzerland sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 150 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 151 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 152 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 153 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 154 Switzerland sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 155 Switzerland sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 156 Switzerland sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 157 Switzerland sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 158 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 159 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 160 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 161 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 162 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 163 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 164 Rest of Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 165 Rest of Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 166 Rest of Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 167 Rest of Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 168 Asia Pacific sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 169 Asia Pacific sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 170 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 171 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 172 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 173 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 174 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 175 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 176 Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 177 Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 178 Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 179 Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 180 China sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 181 China sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 182 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 183 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 184 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 185 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 186 China sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 187 China sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 188 China sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 189 China sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 190 Japan sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 191 Japan sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 192 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 193 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 194 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 195 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 196 Japan sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 197 Japan sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 198 Japan sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 199 Japan sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 200 India sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 201 India sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 202 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 203 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 204 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 205 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 206 India sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 207 India sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 208 India sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 209 India sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 210 Australia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 211 Australia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 212 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 213 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 214 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 215 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 216 Australia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 217 Australia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 218 Australia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 219 Australia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 220 South Korea sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 221 South Korea sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 222 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 223 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 224 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 225 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 226 South Korea sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 227 South Korea sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 228 South Korea sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 229 South Korea sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 230 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 231 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 232 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 233 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 234 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 235 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 236 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 237 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 238 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 239 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 240 Latin America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 241 Latin America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 242 Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 243 Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 244 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 245 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 246 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 247 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 248 Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 249 Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 250 Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 251 Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 252 Brazil sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 253 Brazil sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 254 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 255 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 256 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 257 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 258 Brazil sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 259 Brazil sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 260 Brazil sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 261 Brazil sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 262 Mexico sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 263 Mexico sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 264 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 265 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 266 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 267 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 268 Mexico sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 269 Mexico sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 270 Mexico sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 271 Mexico sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 272 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 273 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 274 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 275 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 276 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 277 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 278 Rest of Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 279 Rest of Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 280 Rest of Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 281 Rest of Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 282 MEA sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 283 MEA sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 284 MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 285 MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 286 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 287 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 288 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 289 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 290 MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 291 MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 292 MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 293 MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 294 South Africa sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 295 South Africa sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 296 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 297 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 298 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 299 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 300 South Africa sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 301 South Africa sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 302 South Africa sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 303 South Africa sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 304 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 305 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 306 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 307 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 308 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 309 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 310 Saudi Arabia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 311 Saudi Arabia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 312 Saudi Arabia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 313 Saudi Arabia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 314 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 315 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 316 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 317 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 318 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 319 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 320 Rest of MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 321 Rest of MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 322 Rest of MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 323 Rest of MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)